Integrative Parenteral Nutrition in Cancer Patients
Integrative Parenteral Nutrition in Hospitalized, Malnourished, Hypophagic Cancer Patients With Contraindication to Enteral Nutrition
Sponsor: Baxter Healthcare Corporation
Listed as NCT02828150, this NA trial focuses on Neoplasms and Parenteral Nutrition and remains completed. Sponsored by Baxter Healthcare Corporation, it has been updated 7 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Jun 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Jun 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Dec 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2017 — Dec 2017 [monthly]
Recruiting NA
First recorded
Jul 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baxter Healthcare Corporation
- Fondazione IRCCS Policlinico San Matteo di Pavia
For direct contact, visit the study record on ClinicalTrials.gov .